研究成果
香港中文大學新聞發佈
27.03.2026
中大研發經動脈碘栓塞化療無水新藥物配方治療肝細胞癌 無惡化存活期顯著延長一倍
CUHK develops new anhydrous drug formulation for TACE Doubles progression-free survival period in patients with hepatocellular carcinoma
16.07.2024
英國皇家放射科醫學院最高榮譽–2024 金獎
Top Honour from The Royal College of Radiologists – 2024 Gold Medal
02.04.2024
中大研發新型納米機械人增強溶栓效果 助減中風患者腦損傷
CUHK develops novel retrievable nanorobots for targeted and enhanced thrombolysis potentially saving stroke patients from brain damage
27.04.2023
國際獎項 - 亞太心血管與介入放射學學會「APSCVIR 2023年度金獎」
International Award – APSCVIR 2023 Gold Medal
08.08.2022
中大研發嶄新治療組合 帶領亞洲策略性抗擊膽管癌
CUHK Leading Asia’s Battle to Improve Bile Duct Cancer Survival Rates by Developing a Novel Combinational Strategy in Clinical Trial
20.04.2021
中大研究團隊開發新一代人工智能系統自動分析新冠肺炎CT影像
CUHK Research Team Develops an AI System for Detecting COVID-19 Infections in CT with a Privacy Preserving Multinational Validation Study
28.03.2021
中大研究團隊控制微型機械人集群在人體血管內導航及定位 加快臨床應用轉化
CUHK Research Team Enables Navigation and Localisation of Microrobotic Swarms in Blood Vessels - Drive Forward Transformation towards Medical Applications
01.02.2021
中大發現能預測「前列腺動脈栓塞術」成效的指標 可避免良性前列腺肥大患者術後出現副作用
CUHK Identifies Outcome Indicators for Benign Prostatic Hyperplasia Patients Receiving Prostatic Artery Embolisation